Medication-Assisted Treatment (MAT)—also referred to as Medications for Opioid Use Disorder (MOUD) and Medications for Alcohol Use Disorder (MAUD)—combines FDA-approved medications with counseling and behavioral therapies. Extensive medical evidence shows that MAT cuts overdose mortality in half, reduces cravings, and improves long-term recovery outcomes.
1. Medications for Opioid Use Disorder (MOUD)
Opioid use disorder alters brain chemistry within mu-opioid receptors. These medications stabilize receptor function to prevent withdrawal and blunt cravings.
- Buprenorphine (Suboxone, Subutex, Sublocade): A partial opioid agonist. It activates opioid receptors enough to suppress withdrawal and eliminate cravings, but features a “ceiling effect” that drastically lowers the risk of respiratory depression and overdose. Available as daily sublingual strips or monthly extended-release injections.
- Methadone: A long-acting full opioid agonist administered through federally certified Opioid Treatment Programs (OTPs). Highly effective for severe opioid dependence and high tolerance from synthetic fentanyl.
- Naltrexone (Vivitrol): An opioid antagonist that binds to and blocks opioid receptors, preventing illicit opioids from producing any euphoric effect. Delivered as a monthly intramuscular injection. Requires 7 to 14 days of complete opioid detoxification prior to initiation.
2. Medications for Alcohol Use Disorder (MAUD)
Three FDA-approved medications support individuals working to reduce or eliminate alcohol intake:
- Acamprosate (Campral): Rebalances neurotransmitter pathways (glutamate and GABA) disrupted by chronic alcohol consumption, helping alleviate the anxiety and physical discomfort associated with post-acute withdrawal.
- Naltrexone (Oral or Vivitrol): Blocks endorphin-mediated pleasure signals triggered by drinking. Over time, reducing the euphoric reward helps extinguish alcohol cravings.
- Disulfiram (Antabuse): Blocks the enzyme that processes alcohol in the liver, causing unpleasant physical reactions (flushing, nausea, headache, palpitations) if alcohol is consumed. Functions as a psychological deterrent.
3. Addressing Common Myths About MAT
| Common Myth | Medical Reality |
| “MAT is just trading one addiction for another.” | Medications maintain neurochemical balance without causing intoxication, allowing people to work, drive, and rebuild daily routines. |
| “You aren’t truly clean if you take medication.” | Major medical institutions (AMA, ASAM, WHO) recognize addiction as a chronic illness; taking prescribed medication is evidence-based healthcare. |
| “You have to take these medications forever.” | Treatment duration is individualized. Some use MAT as a short-term bridge for months, while others safely stay on long-term maintenance. |
Finding a MAT Provider: Doctors, nurse practitioners, and physician assistants can prescribe buprenorphine directly without special federal waiver caps. Visit FindTreatment.gov or call SAMHSA at 1-800-662-4357 to find certified local prescribers.
